Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 15/20 | 0.60 |
| ▸ | SELP | P16109 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22050898 | 0.93 | SELE (0.69) | SELESELP | |
| SCHEMBL22050899 | 0.92 | SELE (0.69) | SELESELP | |
| SCHEMBL22051430 | 0.92 | SELE (0.69) | SELESELP | |
| SCHEMBL22050901 | 0.89 | SELE (0.63) | SELESELP | |
| SCHEMBL22051429 | 0.88 | SELE (0.63) | SELESELP | |
| SCHEMBL22050900 | 0.88 | SELE (0.63) | SELESELP | |
| SCHEMBL22050883 | 0.85 | SELE (0.76) | SELESELP | |
| SCHEMBL22051436 | 0.85 | SELE (0.76) | SELESELP | |
| SCHEMBL22050541 | 0.84 | SELE (0.76) | SELESELP | |
| SCHEMBL22050885 | 0.83 | SELE (0.76) | SELESELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200171005-A9 | Heterobifunctional Pan-Selectin Antagonists Having a Triazole Linker | GLYCOMIMETICS, INC. (US) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200171005-A9 | Heterobifunctional Pan-Selectin Antagonists Having a Triazole Linker | SELE, SELP, SELPLG | SELE 1/4885SELP 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.